The Microinflammatory State in Uremia: Causes and Potential Consequences

作者: George A. Kaysen

DOI: 10.1681/ASN.V1271549

关键词: Serum amyloid AUremiaVascular diseaseDialysisEndocrinologyKidney diseaseInternal medicineProinflammatory cytokineMedicineLipoproteinInflammation

摘要: Mortality is markedly elevated in patients with end-stage renal disease. The leading cause of death cardiovascular Lipoprotein levels are only slightly dialysis patients, and risk inversely correlated serum cholesterol, suggesting that a process other than hyperlipidemia plays role the incidence Hypoalbuminemia, ascribed to malnutrition, has been one most powerful factors predict all-cause mortality patients. presence inflammation, as evidenced by increased specific cytokines (interleukin-6 tumor necrosis factor alpha) or acute-phase proteins (C-reactive protein amyloid A), however, found be associated vascular disease general population well also called response, additionally causes loss muscle mass changes plasma composition-decreases albumin, prealbumin, transferrin levels, malnutrition. Inflammation alters lipoprotein structure function endothelial favor atherogenesis increases concentration atherogenic serum, such fibrinogen (a). episodic. likely multifactorial include access infection, less-than-sterile dialysate, dialysate back leak, nonbiocompatible membranes addition clinically apparent infection. In addition, proinflammatory compounds, advanced glycation end products, accumulate failure, defense mechanisms against oxidative injury reduced, contributing inflammation its effect on endothelium.

参考文章(85)
Günter Weiss, Iron and anemia of chronic disease Kidney International. ,vol. 55, ,(1999) , 10.1046/J.1523-1755.1999.055SUPPL.69012.X
Toshio Miyata, Yasuhiko Ueda, Katsunori Horie, Masaomi Nangaku, Shuichi Tanaka, Charles van Ypersele de Strihou, Kiyoshi Kurokawa, Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney International. ,vol. 53, pp. 416- 422 ,(1998) , 10.1046/J.1523-1755.1998.00756.X
Braden J. Manns, Ellen D. Burgess, M.E. Hyndman, Howard G. Parsons, Jeffrey P. Schaefer, Nairne W. Scott-Douglas, Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease American Journal of Kidney Diseases. ,vol. 34, pp. 669- 677 ,(1999) , 10.1016/S0272-6386(99)70392-6
J.-L. Paul, N.-D. Sall, T. Soni, J.-L. Poignet, A. Lindenbaum, N.-K. Man, N. Moatti, D. Raichvarg, Lipid Peroxidation Abnormalities in Hemodialyzed Patients Nephron. ,vol. 64, pp. 106- 109 ,(1993) , 10.1159/000187287
Glenn M. Chertow, Kirsten L. Johansen, Nancy Lew, J. Michael Lazarus, Edmund G. Lowrie, Vintage, nutritional status, and survival in hemodialysis patients Kidney International. ,vol. 57, pp. 1176- 1181 ,(2000) , 10.1046/J.1523-1755.2000.00945.X
George A. Kaysen, Joel A. Dubin, Hans G. Müller, Laura M. Rosales, Nathan W. Levin, The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients Kidney International. ,vol. 58, pp. 346- 352 ,(2000) , 10.1046/J.1523-1755.2000.00172.X
Jean-Marc Cavaillon, Jean-Louis Poignet, Catherine Fitting, Simone Delons, Serum Interleukin-6 in Long-Term Hemodialyzed Patients Nephron. ,vol. 60, pp. 307- 313 ,(1992) , 10.1159/000186770
B J Van Lenten, S Y Hama, F C de Beer, D M Stafforini, T M McIntyre, S M Prescott, B N La Du, A M Fogelman, M Navab, Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. Journal of Clinical Investigation. ,vol. 96, pp. 2758- 2767 ,(1995) , 10.1172/JCI118345
Geraldine H Clark, Callum G Fraser, Biological Variation of Acute Phase Proteins Annals of Clinical Biochemistry. ,vol. 30, pp. 373- 376 ,(1993) , 10.1177/000456329303000404
Josef Zimmermann, Silke Herrlinger, Antje Pruy, Thomas Metzger, Christoph Wanner, Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney International. ,vol. 55, pp. 648- 658 ,(1999) , 10.1046/J.1523-1755.1999.00273.X